COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,627 Articles (22,913 medRxiv, 8,714 bioRxiv)

Most recent first Previous |  Page 2227: Articles 22261-22270  | Next

Pathogenesis-based pre-exposure prophylaxis associated with low risk of SARS-CoV-2 infection in healthcare workers at a designated Covid-19 hospital
Dubina, M. V., Gomonova, V. V., Taraskina, A. E., Vasilyeva, N. V., Sayganov, S. A.
10.1101/2020.09.25.20199562 — Posted: 2020-10-06
Which factors should be included in triage? An online survey of the attitudes of the UK general public to pandemic triagedilemmas
Wilkinson, D., Zohny, H., Kappes, A., Sinnott-Armstrong, W., Savulescu, J.
10.1101/2020.10.06.20207662 — Posted: 2020-10-06
Characteristics and outcomes of hospitalized adults with COVID-19 in Nepal: a multicenter, prospective cohort study
Chaudhary, A., Singh, U. N., Paudel, P., Thapa, N., Khadka, K., Sah, P. K., Kamar, S. B., Joshi, J., Ansari, K. H., Tiwari, S. R., Sharma, S., Jaiswal, S. K., Joshi, R., Baskota, S., Tiwari, A. P., Pandey, H. R.
10.1101/2020.10.03.20206128 — Posted: 2020-10-06
Incidence and Case-Fatality Ratio of COVID-19 infection in relation to Tobacco Smoking, Population Density and Age Demographics in the USA : could Particulate Matter derived from Tobacco Smoking act as a Vector for COVID-19 transmission?
Baron, Y. M.
10.1101/2020.10.04.20206383 — Posted: 2020-10-06
Prevalence of SARS-CoV-2 in human post-mortem ocular tissues
Sawant, O. B., Singh, S., Wright, R. E., Jones, K. M., Titus, M. S., Dennis, E., Hicks, E., Majmudar, P. A., Kumar, A., Mian, S. I.
10.1101/2020.10.05.20201574 — Posted: 2020-10-06
Scalable, effective, and rapid decontamination of SARS-CoV-2 contaminated N95 respirators using germicidal ultra-violet C (UVC) irradiation device
Rathnasinghe, R., Karlicek, R. F., Schotsaert, M., Koffas, M. A., Arduini, B., Jangra, S., Wang, B., Davis, J. L., Alnaggar, M., Costa, A., Vincent, R., Garcia-Sastre, A., Vashishth, D., Balchandani, P.
10.1101/2020.10.05.20206953 — Posted: 2020-10-06
An Agent Based Model for assessing spread and health systems burden for COVID-19 using a synthetic population in Telangana state, India
MS, N., Jammy, G. R., A, S., Pant, R., SP, A., Choudhury, L., Yeldandi, V., Singh, S., John, D.
10.1101/2020.10.03.20206177 — Posted: 2020-10-06
Vulnerability and burden of all-cause mortality associated with particulate air pollution increased during COVID-19 pandemic: a nationwide observed study in Italy
Ye, T., Xu, R., Yu, W., Chen, Z., Guo, Y., Li, S.
10.1101/2020.10.02.20206052 — Posted: 2020-10-06
The impact of the COVID-19 pandemic on families in Germany
Branstetter, S., Poulain, T., Vogel, M., Meigen, C., Melter, M., Seelbach-Goebel, B., Apfelbacher, C., Kiess, W., Kabesch, M., Koerner, A.
10.1101/2020.10.05.20206805 — Posted: 2020-10-06
A Data-Informed Approach for Analysis, Validation, and Identification of COVID-19 Models
Olmez, S. Y., Mori, J., Miehling, E., Basar, T., Smith, R. L., West, M., Mehta, P. G.
10.1101/2020.10.03.20206250 — Posted: 2020-10-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).